PT - JOURNAL ARTICLE AU - Cheung, Chun Chau Lawrence AU - Goh, Denise AU - Lim, Xinru AU - Tien, Tracy Zhijun AU - Lim, Jeffrey Chun Tatt AU - Nerurkar, Sanjna Nilesh AU - Shihleone, Loong AU - Cheow, Peng Chung AU - Chan, Chung Yip AU - Koh, Ye Xin AU - Tan, Thuan Tong AU - Kalimuddin, Shirin AU - David Tai, Wai Meng AU - Ng, Jia Lin AU - Hong Low, Jenny Guek AU - Yeong, Joe AU - Hon Lim, Tony Kiat TI - Residual SARS-CoV-2 viral antigens detected in gastrointestinal and hepatic tissues from two recovered COVID-19 patients AID - 10.1101/2020.10.28.20219014 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.28.20219014 4099 - http://medrxiv.org/content/early/2020/11/03/2020.10.28.20219014.short 4100 - http://medrxiv.org/content/early/2020/11/03/2020.10.28.20219014.full AB - Residual SARS-CoV-2 RNA has been detected in stool samples and gastrointestinal tissues during the convalescence phase of COVID-19 infection. This raises concern for persistence of SARS-CoV-2 virus particles and faecal-oral transmissibility in recovered COVID-19 patients. Using multiplex immunohistochemistry, we unexpectedly detected SARS-CoV-2 viral antigens in intestinal and liver tissues, in surgical samples obtained from two patients who recovered from COVID-19. We further validated the presence of virus by RT-PCR and flow cytometry to detect SARS-CoV-2-specific immunity in the tissues. These findings might have important implications in terms of disease management and public health policy regarding transmission of COVID-19 via faecal-oral and iatrogenic routes during the convalescence phase.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is supported by the Centre Grant of Singapore General Hospital (grant no. NMRC/CG/M011/2017_SGH)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the SingHealth Centralised Institutional Review Board (reference number: 2019/2653).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available from the corresponding authors upon reasonable request.